Flavia Borellini
Direttore/Membro del Consiglio presso REVOLUTION MEDICINES, INC.
Patrimonio netto: 375 381 $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Mark Goldsmith | M | 62 | 10 anni | |
| Iain Dukes | M | 65 |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | 7 anni |
| Gottlieb A. Keller | M | 70 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | 40 anni |
| Melody Burcar | F | 41 | 2 anni | |
| Roger Pomerantz | M | 67 | 4 anni | |
| Mark Rothera | M | 61 | 2 anni | |
| Göran Forsberg | M | 61 | 10 anni | |
| Thoas Michael Fioretos | M | 66 | 15 anni | |
| Jane Chung | F | 53 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 anni |
| Jeff Cislini | M | 49 | 4 anni | |
| Ivor Royston | M | 79 | 17 anni | |
| Michel Demaré | M | 67 | 5 anni | |
| Wayne P. Rothbaum | M | 56 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands.
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | 4 anni |
| Peg Horn | M | 61 | - | |
| Karin Leandersson | F | 52 | 8 anni | |
| Elizabeth Anderson | F | 66 | 9 anni | |
| Sandra Horning | M | 75 | 1 anni | |
| Lorence Kim | M | 49 | 2 anni | |
| Sushil Patel | M | 52 | 2 anni | |
| Thilo Schroeder | M | 42 | 6 anni | |
| Jane Barlow | M | 63 | 3 anni | |
| Thomas Darcy | M | 74 | 3 anni | |
| Patricia Delaite | M | 61 | 7 anni | |
| Shu Kam Mok | M | 63 | 5 anni | |
| Barbara Weber | M | 67 | 6 anni | |
| Jack Anders | M | 47 | 6 anni | |
| Jesse Seton McGreivy | M | 54 |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | - |
| Stephen Rubino | M | 65 | 3 anni | |
| Ashleigh Barreto | F | - | 3 anni | |
| Damian Marron | M | 62 | 3 anni | |
| Magnus Nilsson | M | 68 | 3 anni | |
| Alexis Borisy | M | 52 | 10 anni | |
| Gunnar Magnus Modee Persson | M | 64 | 8 anni | |
| Barry Simon | M | 59 | 3 anni | |
| Anders Martin-Löf | M | 53 | 6 anni | |
| Sam Murphy | M | 47 | 5 anni | |
| Cindy Hoots | F | 56 | 4 anni | |
| Daniel Simon | M | - | 2 anni | |
| Linnet Zia | F | - | 5 anni | |
| Darrel Cohen | M | 59 | 1 anni | |
| Donald Strickland | M | - | - | |
| Kara Lassen | M | 45 |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | 7 anni |
| Biljana Nadjsombati | F | - | 3 anni | |
| Patric Nelson | M | - | 3 anni | |
| Ayman El-Guindy | M | - | 3 anni | |
| Wally Reiher | M | - | 9 anni | |
| Patrik Renblad | M | 54 | 1 anni | |
| Steven Pemberton | M | - |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | - |
| Cheryl A. Madsen | F | - | - | |
| Frank Lee | M | 56 |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | - |
| David Liberg | M | 55 | 9 anni | |
| Wei Lin | M | 63 | 1 anni | |
| Lars Thorsson | M | 63 | 9 anni | |
| Dominique Tersago | M | 62 | 2 anni | |
| Stewart M. Brown | M | - | 2 anni | |
| Maria Fardis | M | 56 |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | - |
| Nedjad Losic | M | 54 | 3 anni | |
| Liselotte Larsson | M | 61 | 10 anni | |
| Severin Schwan | M | 57 |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | 16 anni |
| Luan M. Wilfong | F | - | - | |
| Steve Kelsey | M | 63 | 7 anni | |
| Roger Ulrich | M | - |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | - |
| Alan Hippe | M | 57 |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | - |
| Shishir Gadam | M | 57 |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Daniel Chevallard | M | 44 | 5 anni | |
| David J. Scott | M | 71 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Gur Roshwalb | M | 55 | 1 anni | |
| Shelly Vandertie | F | - | - | |
| Michael Huang | M | 50 | 3 anni | |
| Francisco Salva | M | 53 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 4 anni |
| Vincent A. Miller | M | 62 | 5 anni | |
| Shriti Vadera | F | 62 | 7 anni | |
| Pablo Cagnoni | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 anni |
| Joseph Peter | M | 60 | - | |
| Neil Exter | M | 65 | 3 anni | |
| José Baselga | M | 65 | 2 anni | |
| Peter Svennilson | M | 62 | 1 anni | |
| William Ringo | M | 78 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 anni |
| Antonio J. Grillo-López | M | 84 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 11 anni |
| Paul Goddard | M | 74 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 16 anni |
| Wendell Wierenga | M | 76 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 17 anni |
| Magnus Åke Lundberg | M | 68 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 13 anni |
| Nicole Onetto | M | 71 | 2 anni | |
| Thomas Wiggans | M | 72 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 8 anni |
| Rudolph Markham | M | 78 | 11 anni | |
| Eric Schmidt | M | 55 | 3 anni | |
| JoAnn Suzich | M | 68 | 1 anni | |
| Kevin J. Horgan | M | 64 | 3 anni | |
| David Wheadon | M | 66 | 5 anni | |
| Bahija Jallal | M | 62 | 11 anni | |
| Fiona Cicconi | F | 58 | 6 anni | |
| Jean-Charles Soria | M | 53 | 2 anni | |
| Robin LaChapelle | F | 51 | 4 anni | |
| Jim Kastenmayer | M | 52 | 7 anni | |
| Henry Cremisi | M | 66 | 3 anni | |
| Britton A. Russell | M | 35 | 1 anni | |
| Tausif Butt | M | 57 | 2 anni | |
| Stephen Hill | M | 53 | 3 anni | |
| Mitchell Goldman | M | - | 21 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 57 | 57.58% |
| Regno Unito | 20 | 20.20% |
| Svezia | 14 | 14.14% |
| Svizzera | 7 | 7.07% |
| Paesi Bassi | 2 | 2.02% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Flavia Borellini
- Contatti personali
